Clinical trial
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
NCT05274945 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
- Lead sponsor
- Alexandria University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- January 1, 2022
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer